Jasper Therapeutics (JSPR) Institutional Ownership

→ Don’t expose yourself to stocks during the week (From DTI) (Ad)

Free JSPR Stock Alerts

$23.21

-0.61 (-2.56%)

(As of 04/18/2024 ET)

Compare

Current Institutional Ownership Percentage: 79.85%
Number of Institutional Buyers (last 12 months): 33
Total Institutional Inflows (last 12 months): $826.81M

Number of Institutional Sellers (last 12 months): 5
Total Institutional Outflows (last 12 months): $43.35M

Get JSPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

JSPR Institutional Buying and Selling by Quarter

Ad DTI

Special FREE offer on stock hotsheets

These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?

Click here and I’ll show you

Jasper Therapeutics Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/18/2024	Kingdon Capital Management L.L.C.	3,540,000	$2.79M	0.3%	+16.4%	31.720%
3/11/2024	Vanguard Group Inc.	4,092,958	$3.23M	0.0%	+7.9%	36.675%
2/15/2024	Sphera Funds Management LTD.	713,063	$563K	0.1%	-87.5%	6.391%
2/15/2024	Vanguard Group Inc.	4,092,958	$3.23M	0.0%	+7.9%	36.682%
2/15/2024	Opaleye Management Inc.	3,985,340	$3.14M	0.8%	N/A	35.717%
2/7/2024	Ieq Capital LLC	54,500	$43K	0.0%	N/A	0.488%
Get the Latest News and Ratings for JSPR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
2/7/2024	Monaco Asset Management SAM	249,563	$197K	0.1%	N/A	2.236%
2/5/2024	Fernwood Investment Management LLC	494,706	$390K	0.1%	+8.8%	4.433%
12/18/2023	Vanguard Group Inc.	3,792,958	$2.66M	0.0%	+2.8%	3.400%
11/13/2023	Mariner LLC	652,749	$457K	0.0%	-8.7%	0.589%
11/9/2023	Cowen AND Company LLC	200,393	$140K	0.0%	N/A	0.181%
11/8/2023	Forefront Analytics LLC	110,792	$78K	0.0%	+59.7%	0.100%
10/30/2023	Summit Trail Advisors LLC	65,000	$46K	0.0%	N/A	0.059%
8/15/2023	Gries Financial LLC	23,845	$33K	0.0%	N/A	0.022%
8/15/2023	Sphera Funds Management LTD.	4,274,008	$5.86M	0.9%	+5.7%	3.874%
8/14/2023	Jefferies Financial Group Inc.	489,884	$671K	0.0%	N/A	0.444%
8/11/2023	Renaissance Technologies LLC	58,100	$80K	0.0%	-47.3%	0.053%
8/11/2023	BlackRock Inc.	1,332,347	$1.83M	0.0%	+6.0%	1.208%
8/11/2023	Geode Capital Management LLC	965,504	$1.32M	0.0%	-9.8%	0.875%
6/1/2023	Prelude Capital Management LLC	54,500	$99K	0.0%	N/A	0.049%
5/16/2023	Jane Street Group LLC	211,010	$382K	0.0%	N/A	0.193%
5/16/2023	Sphera Funds Management LTD.	4,044,008	$7.32M	1.2%	N/A	3.697%
5/16/2023	State Street Corp	199,094	$360K	0.0%	+505.4%	0.182%
5/16/2023	Squarepoint Ops LLC	139,887	$253K	0.0%	N/A	0.128%
5/16/2023	Geode Capital Management LLC	1,070,314	$1.94M	0.0%	+740.0%	0.979%
5/16/2023	Ally Bridge Group NY LLC	2,517,232	$4.56M	6.0%	N/A	2.301%
5/16/2023	BVF Inc. IL	9,900,000	$17.92M	0.7%	N/A	9.051%
5/15/2023	Affinity Asset Advisors LLC	476,948	$863K	0.3%	N/A	0.436%
5/15/2023	Two Sigma Investments LP	42,253	$76K	0.0%	N/A	0.039%
5/15/2023	Kingdon Capital Management L.L.C.	3,040,000	$5.50M	1.0%	+463.0%	2.779%
5/15/2023	Boothbay Fund Management LLC	233,407	$422K	0.0%	N/A	0.213%
5/15/2023	RTW Investments LP	2,329,809	$4.22M	0.1%	N/A	2.130%
5/12/2023	Renaissance Technologies LLC	110,200	$199K	0.0%	+68.5%	0.101%
5/12/2023	BlackRock Inc.	1,256,517	$2.27M	0.0%	+486.8%	1.149%
5/12/2023	Bank of America Corp DE	1,781,583	$3.23M	0.0%	+4,948,741.7%	1.629%
5/12/2023	Franklin Resources Inc.	4,500,217	$8.15M	0.0%	N/A	4.114%
5/12/2023	Charles Schwab Investment Management Inc.	36,899	$67K	0.0%	N/A	0.034%
5/12/2023	Forefront Analytics LLC	30,290	$55K	0.0%	-73.4%	0.028%
5/11/2023	Citigroup Inc.	64,810	$117K	0.0%	N/A	0.059%
5/9/2023	Bank of New York Mellon Corp	43,593	$79K	0.0%	N/A	0.040%
Healthcare Takes A Big Step Forward With The Help Of AI (Ad) The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+. Click here to see why this small company is trusted by the Mayo Clinic
5/5/2023	Carlyle Group Inc.	8,761,891	$15.77M	0.5%	N/A	8.011%
5/3/2023	Jump Financial LLC	33,074	$60K	0.0%	N/A	0.030%
4/25/2023	Qiming U.S. Ventures Management LLC	8,519,648	$15.42M	18.7%	+45.6%	7.789%
2/13/2023	Forefront Analytics LLC	114,000	$55K	0.0%	-4.8%	0.300%
2/13/2023	Renaissance Technologies LLC	65,400	$32K	0.0%	+128.7%	0.172%
2/8/2023	UBS Group AG	215,521	$103K	0.0%	+14.6%	0.567%
2/7/2023	Fernwood Investment Management LLC	454,706	$220K	0.1%	+53.1%	1.197%
11/15/2022	Vanguard Group Inc.	530,120	$418K	0.0%	+10.3%	1.445%
11/15/2022	Citadel Advisors LLC	3,102,016	$2.45M	0.0%	+3.8%	8.455%
11/14/2022	Forefront Analytics LLC	119,800	$94K	0.1%	+246.0%	0.327%
11/10/2022	UBS Group AG	188,026	$148K	0.0%	+3,294.6%	0.512%
11/9/2022	Fernwood Investment Management LLC	297,080	$234K	0.1%	N/A	0.810%
8/15/2022	State Street Corp	32,884	$63K	0.0%	+51.2%	0.087%
5/16/2022	Goldman Sachs Group Inc.	10,451	$37K	0.0%	-41.1%	0.028%
5/16/2022	State Street Corp	21,752	$77K	0.0%	N/A	0.057%
5/13/2022	Renaissance Technologies LLC	10,871	$39K	0.0%	N/A	0.029%
5/13/2022	Federated Hermes Inc.	251,697	$894K	0.0%	-79.1%	0.665%
5/13/2022	Vanguard Group Inc.	477,824	$1.70M	0.0%	-1.2%	1.262%
5/10/2022	Sectoral Asset Management Inc.	675,000	$2.40M	0.4%	N/A	1.782%
5/9/2022	Forefront Analytics LLC	32,550	$118K	0.0%	N/A	0.086%
4/27/2022	Vahanian & Associates Financial Planning Inc.	10,000	$36K	0.1%	-60.0%	0.026%
2/15/2022	Kingdon Capital Management L.L.C.	540,000	$4.24M	0.5%	N/A	1.427%
2/2/2022	Grace Capital	218,110	$1.71M	1.0%	N/A	0.576%
1/28/2022	Vahanian & Associates Financial Planning Inc.	25,000	$196K	0.2%	N/A	0.066%
11/16/2021	Citadel Advisors LLC	3,005,035	$29.22M	0.0%	N/A	8.228%
11/15/2021	Tudor Investment Corp Et Al	20,000	$205K	0.0%	N/A	0.055%
11/15/2021	Abingworth LLP	5,628,558	$58.03M	13.2%	N/A	15.412%

(Data available from 1/1/2016 forward)

JSPR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of JSPR shares?: During the previous two years, 40 institutional investors and hedge funds held shares of Jasper Therapeutics. The most heavily invested institutionals were BVF Inc. IL ($17.92M), Carlyle Group Inc. ($15.77M), Qiming U.S. Ventures Management LLC ($15.42M), Franklin Resources Inc. ($8.15M), Ally Bridge Group NY LLC ($4.56M), RTW Investments LP ($4.22M), and Vanguard Group Inc. ($3.23M).Learn more on JSPR's institutional investors.
What percentage of Jasper Therapeutics stock is owned by institutional investors?: 79.85% of Jasper Therapeutics stock is owned by institutional investors. Learn more on JSPR's institutional investor holdings.
Which institutional investors have been buying Jasper Therapeutics stock?: Of the 36 institutional investors that purchased Jasper Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($9.90M), Carlyle Group Inc. ($8.76M), Franklin Resources Inc. ($4.50M), Sphera Funds Management LTD. ($4.27M), Opaleye Management Inc. ($3.99M), Kingdon Capital Management L.L.C. ($3M), and Qiming U.S. Ventures Management LLC ($2.67M).

How much institutional buying is happening at Jasper Therapeutics?: Institutional investors have bought a total of 50,894,873 shares in the last 24 months. This purchase volume represents approximately $860.11M in transactions.
Which Jasper Therapeutics major shareholders have been selling company stock?: Of the 9 institutional investors that sold Jasper Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Sphera Funds Management LTD. ($4.97M), Federated Hermes Inc. ($954.88K), Geode Capital Management LLC ($104.81K), Forefront Analytics LLC ($89.51K), Mariner LLC ($62.25K), Renaissance Technologies LLC ($52.10K), and Vahanian & Associates Financial Planning Inc. ($15K).
How much institutional selling is happening at Jasper Therapeutics?: Institutional investors have sold a total of 6,265,595 shares in the last 24 months. This volume of shares sold represents approximately $78.27M in transactions.

Related Companies:

This page (NASDAQ:JSPR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Jasper Therapeutics (JSPR) Institutional Ownership

JSPR Institutional Buying and Selling by Quarter

Jasper Therapeutics Major Shareholders & Ownership History

JSPR Institutional Ownership - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Jasper Therapeutics (JSPR) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Jasper Therapeutics (NASDAQ:JSPR)

JSPR Institutional Buying and Selling by Quarter

Jasper Therapeutics Major Shareholders & Ownership History

JSPR Institutional Ownership - Frequently Asked Questions